Target intelligence / Profile preview

ATP synthase membrane subunit g, mitochondrial (ATP5MG)

Target
ATP5MG
Molecular classification
Enzyme (ATP synthase complex subunit), Transporter (proton transporter as part of complex V), Other (multisubunit complex)
01

Overview

ATP synthase membrane subunit g (mitochondrial), encoded by the ATP5MG gene, is a component of the F₀ sector of mitochondrial ATP synthase (Complex V). This multi-subunit enzyme complex synthesizes ATP by converting ADP and inorganic phosphate, utilizing the proton gradient generated by electron transport chain activity. The F₀ subunit forms the transmembrane proton channel, where subunit g associates as a minor peripheral component. Subunit g is unique to mitochondrial ATP synthase in animals and is not found in bacterial or chloroplast ATP synthases. Its specific structural and functional roles remain incompletely understood, but it is implicated in complex organization and proton translocation necessary for catalysis. Defects in subunit g or other complex V subunits can cause mitochondrial diseases characterized by impaired energy metabolism and multi-system dysfunction.

Other names
ATP5MGATP synthase F(0) complex subunit g, mitochondrialATP5LATPase subunit gATP5JGATP synthase membrane subunit gATP synthase g chain, mitochondrialATP synthase subunit g, mitochondrialATP synthase, H+ transporting, mitochondrial F0 complex, subunit GF1F0-type ATP synthase subunit gF1Fo-ATP synthase complex Fo membrane domain g subunit
02

Mechanism of action

Inhibition of ATP synthase function via blocking proton translocation (for drugs like oligomycin and DCCD)

03

Biological functions

ATP synthesis via oxidative phosphorylationProton translocation across mitochondrial inner membraneCellular energy production
04

Disease associations

Mitochondrial diseaseCombined oxidative phosphorylation deficiency 8
05

Safety considerations

Global ATP synthase inhibition (including ATP5MG targeting) threatens cellular ATP supply and overall viability, limiting therapeutic index. Potential for off-target mitochondrial toxicity, myopathy, cardiomyopathy
06

Interacting drugs

Oligomycin

2 more in the full profile.

07

Biomarkers

Mutations in ATP5MG may be evaluated in studies of mitochondrial dysfunction but not routinely used as standard prospective biomarkers

Beyond the preview

Go deeper on ATP synthase membrane subunit g, mitochondrial (ATP5MG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase membrane subunit g, mitochondrial (ATP5MG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call